Ask AI

The Next Frontier: Rapid AST to Optimize Care of Patients With Bloodstream Infections

Lead the way to the “next frontier” of care for patients with bloodstream infections (BSIs). With this program, you can gain strategies for timely assessment of antimicrobial susceptibility (AST) of Gram-negative BSIs with rapid phenotypic AST platforms and learn about optimal implementation of rapid AST for patients with sepsis.

Share

Program Content

Events

Activities

Gram Negative BSIs
The Burden of Gram-negative Bloodstream Infections and Value of Rapid Antimicrobial Susceptibility Testing
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with ProCE

Supporters

Supported by an educational grant from bioMérieux.

bioMérieux

Partners

ProCE

ProCE Banner